Global car shares slide amid lower demand in China – what happens now?
Has the car sector run into trouble? Britain’s Aston Martin and Germany’s Volkswagen are among the key automobile brands that have issued profit warnings.
Shares in luxury carmaker Aston Martin crashed by 20% after new CEO Adrian Hallmark admitted the company will have to cut targets for car production by a further 14%, say Robert Lea and Martin Strydom in The Times. These cuts, which mean production will now be down 40% from earlier predictions, are due to disruption in the supply chain, with “a number of its suppliers going bankrupt as well as continued macroeconomic weakness in China”. As a result, the company “will not be cash-flow positive in the second half of 2024”.
No wonder the stock slipped, says Hargreaves Lansdown’s Aarin Chiekrie. It’s impossible to rule out “further disappointments down the road”. The high debt level is a “real problem” and “makes it difficult to obtain additional debt financing should demand slip and the group run into trouble”. However, Aston Martin’s “high price point arguably offers it some level of protection” from general auto trends, given its buyers “aren’t typically short of cash”. This is important given that the group is “not alone in its struggles”. For some other carmakers, the outlook for demand is far worse.
Demand for global carmakers drops in China
Aston Martin is certainly not the only car company in trouble, says Lex in the Financial Times. Shares in the Netherlands’ Stellantis, which makes Peugeot, Fiat, Chrysler and Jeep vehicles, have also slipped after it predicted lower profits. And Germany’s Volkswagen lowered its annual guidance for the second time in three months on 27 September, while Mercedes-Benz and BMW have also issued profit warnings. All these firms are suffering from problems in the industry’s supply chains; moreover, sales of foreign cars have slid sharply in China.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The lack of demand in China is particularly worrying for Volkswagen, Mercedes and BMW as they have now become “increasingly reliant” on selling vehicles to China’s “burgeoning upper middle class”, says Louis Goss on MarketWatch. They hope the fall in sales will end once the property market bottoms. However, the government is cracking down on “wealth flaunting” behaviours, while Chinese consumers are now increasingly starting to favour locally made cars, which are far cheaper and offer superior technology. European carmakers may, therefore, continue to lose market share.
Still, the car manufacturers’ difficulties may help the industry as they come at a “pivotal time”, says Neil Unmack on Breakingviews. European policymakers are about to make a decision on whether to go through with fines on companies for not meeting targets on carbon emissions. The case for at least a partial delay is now “strong”. Fears of increased Chinese competition will also “reinforce the case for tariffs, which many countries, including Spain and Germany, have been opposing”. Still, even if such policy help appears, it may be too little, too late. Stellantis and Volkswagen now trade at just 2.7 and 3.3 times trailing earnings: a “cry for help”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.
Alex is an investment writer who has been contributing to MoneyWeek since 2015. He has been the magazine’s markets editor since 2019.
Alex has a passion for demystifying the often arcane world of finance for a general readership. While financial media tends to focus compulsively on the latest trend, the best opportunities can lie forgotten elsewhere.
He is especially interested in European equities – where his fluent French helps him to cover the continent’s largest bourse – and emerging markets, where his experience living in Beijing, and conversational Chinese, prove useful.
Hailing from Leeds, he studied Philosophy, Politics and Economics at the University of Oxford. He also holds a Master of Public Health from the University of Manchester.
-
Pundits had a bad 2025 – here's what it means for investorsThe pundits came in for many shocks in 2025, says Max King. Here is what they should learn from them
-
The MoneyWeek ETF portfolio – early 2026 updateThe MoneyWeek ETF portfolio had a solid year in 2025 and looks well placed for what the next 12 months may bring
-
Pundits had a bad 2025 – here's what it means for investorsThe pundits came in for many shocks in 2025, says Max King. Here is what they should learn from them
-
The MoneyWeek ETF portfolio – early 2026 updateThe MoneyWeek ETF portfolio had a solid year in 2025 and looks well placed for what the next 12 months may bring
-
'Investors should brace for Trump’s great inflation'Opinion Donald Trump's actions against Federal Reserve chair Jerome Powell will likely stoke rising prices. Investors should prepare for the worst, says Matthew Lynn
-
The state of Iran’s collapsing economy – and why people are protestingIran has long been mired in an economic crisis that is part of a wider systemic failure. Do the protests show a way out?
-
Review: Castiglion del Bosco, A Rosewood Hotel – a Tuscan rural idyllTravel Play golf, drink exquisite wine and eat good food at Castiglion del Bosco, A Rosewood Hotel, all within the stunning Val d’Orcia National Park in Tuscany
-
The rise and fall of Nicolás Maduro, Venezuela's ruthless dictatorNicolás Maduro is known for getting what he wants out of any situation. That might be a challenge now
-
Polar Capital: a cheap, leveraged play on technologyPolar Capital has carved out a niche in fund management and is reaping the benefits
-
Vaccines inject billions into Big Pharma – how to profit from the sectorThe vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Here's what it means for investors